. 2024 Jun;24(6):918-927.

doi: 10.1016/j.ajt.2024.03.015. Epub 2024 Mar 19.

Research opportunities and ethical considerations for heart and lung xenotransplantation research: A report from the National Heart, Lung, and Blood Institute workshop

Kiran K Khush¹, James L Bernat², Richard N Pierson 3rd³, Henry J Silverman⁴, Brendan Parent⁵, Alexandra K Glazier⁶, Andrew B Adams⁷, Jay A Fishman⁸, Michael Gusmano⁹, Wayne J Hawthorne¹⁰, Mary E Homan¹¹, Daniel J Hurst¹², Stephen Latham¹³, Chung-Gyu Park¹⁴, Karen J Maschke¹⁵, Muhammad M Mohiuddin¹⁶, Robert A Montgomery¹⁷, Jonah Odim¹⁸, Rebecca D Pentz¹⁹, Bruno Reichart²⁰, Julian Savulescu²¹, Paul Root Wolpe²², Renee P Wong²³, Kathleen N Fenton²⁴

Affiliations

¹ Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA. Electronic address: kiran@stanford.edu.
² Department of Neurology, Dartmouth Geisel School of Medicine, Hanover, New Hampshire, USA.
³ Department of Surgery and Center for Transplantation Sciences, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
⁴ Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
⁵ Department of Population Health, New York University Grossman School of Medicine, New York, New York, USA.
⁶ New England Donor Services, Waltham, Massachusetts, USA; School of Public Health, Brown University, Providence, Rhode Island, USA.
⁷ Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA.
⁸ Transplant Infectious Disease and MGH Transplant Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
⁹ College of Health, Lehigh University, Bethlehem, Pennsylvania, USA.
¹⁰ Department of Surgery, Westmead Hospital, University of Sydney, Westmead, New South Wales, Australia.
¹¹ Department of Theology and Ethics, CommonSpirit Health, Chicago, Illinois, USA.
¹² Department of Family Medicine, Rowan University School of Osteopathic Medicine, Stratford, New Jersey, USA.
¹³ Interdisciplinary Center for Bioethics, Yale University, New Haven, Connecticut, USA.
¹⁴ Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, South Korea.
¹⁵ The Hastings Center, Garrison, New York, USA.
¹⁶ Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.
¹⁷ NYU Langone Transplant Institute, NYU Langone Health, New York, New York, USA.
¹⁸ Transplantation Branch, Division of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
¹⁹ Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.
²⁰ Department of Cardiac Surgery, Ludwig-Maximillian University, Munich, Germany.
²¹ Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
²² Center for Ethics and Department of Medicine, Emory University, Atlanta, Georgia, USA.
²³ Heart Failure and Arrhythmias Branch, Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
²⁴ Advanced Technologies and Surgery Branch, Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, and Department of Bioethics, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.

PMID: 38514013
PMCID: PMC11144553
DOI: 10.1016/j.ajt.2024.03.015

Research opportunities and ethical considerations for heart and lung xenotransplantation research: A report from the National Heart, Lung, and Blood Institute workshop

Kiran K Khush et al. Am J Transplant. 2024 Jun.

. 2024 Jun;24(6):918-927.

doi: 10.1016/j.ajt.2024.03.015. Epub 2024 Mar 19.

Authors

Affiliations

¹ Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA. Electronic address: kiran@stanford.edu.
² Department of Neurology, Dartmouth Geisel School of Medicine, Hanover, New Hampshire, USA.
³ Department of Surgery and Center for Transplantation Sciences, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
⁴ Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
⁵ Department of Population Health, New York University Grossman School of Medicine, New York, New York, USA.
⁶ New England Donor Services, Waltham, Massachusetts, USA; School of Public Health, Brown University, Providence, Rhode Island, USA.
⁷ Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA.
⁸ Transplant Infectious Disease and MGH Transplant Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
⁹ College of Health, Lehigh University, Bethlehem, Pennsylvania, USA.
¹⁰ Department of Surgery, Westmead Hospital, University of Sydney, Westmead, New South Wales, Australia.
¹¹ Department of Theology and Ethics, CommonSpirit Health, Chicago, Illinois, USA.
¹² Department of Family Medicine, Rowan University School of Osteopathic Medicine, Stratford, New Jersey, USA.
¹³ Interdisciplinary Center for Bioethics, Yale University, New Haven, Connecticut, USA.
¹⁴ Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, South Korea.
¹⁵ The Hastings Center, Garrison, New York, USA.
¹⁶ Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.
¹⁷ NYU Langone Transplant Institute, NYU Langone Health, New York, New York, USA.
¹⁸ Transplantation Branch, Division of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
¹⁹ Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.
²⁰ Department of Cardiac Surgery, Ludwig-Maximillian University, Munich, Germany.
²¹ Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
²² Center for Ethics and Department of Medicine, Emory University, Atlanta, Georgia, USA.
²³ Heart Failure and Arrhythmias Branch, Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
²⁴ Advanced Technologies and Surgery Branch, Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, and Department of Bioethics, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.

PMID: 38514013
PMCID: PMC11144553
DOI: 10.1016/j.ajt.2024.03.015

Abstract

Xenotransplantation offers the potential to meet the critical need for heart and lung transplantation presently constrained by the current human donor organ supply. Much was learned over the past decades regarding gene editing to prevent the immune activation and inflammation that cause early organ injury, and strategies for maintenance of immunosuppression to promote longer-term xenograft survival. However, many scientific questions remain regarding further requirements for genetic modification of donor organs, appropriate contexts for xenotransplantation research (including nonhuman primates, recently deceased humans, and living human recipients), and risk of xenozoonotic disease transmission. Related ethical questions include the appropriate selection of clinical trial participants, challenges with obtaining informed consent, animal rights and welfare considerations, and cost. Research involving recently deceased humans has also emerged as a potentially novel way to understand how xeno-organs will impact the human body. Clinical xenotransplantation and research involving decedents also raise ethical questions and will require consensus regarding regulatory oversight and protocol review. These considerations and the related opportunities for xenotransplantation research were discussed in a workshop sponsored by the National Heart, Lung, and Blood Institute, and are summarized in this meeting report.

Keywords: donors; ethics; research; xenotransplantation.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors of this manuscript have conflicts of interest to disclose as described by the American Journal of Transplantation. Kiran K. Khush: recipient of NHLBI research grant on donor heart evaluation for transplantation (R01HL125303). Brendan Parent: recipient of Applebaum Foundation grant to study ethics of xenotransplantation. Karen J. Maschke and Michael Gusmano: recipients of NCATS research grant on ethical translation of xenotransplantation clinical trials (1R01TR003844-0). The views expressed in this manuscript are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute; the National Institutes of Health; or the U.S. Department of Health and Human Services.

Cited by

Designer Organs: Ethical Genetic Modifications in the Era of Machine Perfusion.
Filz von Reiterdank I, Bento R, Hyun I, Isasi R, Wolf SM, Coert JH, Mink van der Molen AB, Parekkadan B, Uygun K. Filz von Reiterdank I, et al. Annu Rev Biomed Eng. 2025 May;27(1):101-128. doi: 10.1146/annurev-bioeng-062824-121925. Epub 2025 Jan 28. Annu Rev Biomed Eng. 2025. PMID: 39874605 Review.
Ex Vivo Machine Perfusion as a Platform for Lentiviral Gene Delivery in Rat Livers.
Filz von Reiterdank I, Mojoudi M, Bento R, Taggart M, Dinicu A, Wojtkiewicz G, Coert JH, van der Molen AM, Weissleder R, Parekkadan B, Uygun K. Filz von Reiterdank I, et al. Res Sq [Preprint]. 2024 Sep 13:rs.3.rs-4784505. doi: 10.21203/rs.3.rs-4784505/v1. Res Sq. 2024. Update in: Gene Ther. 2025 Jul;32(4):421-429. doi: 10.1038/s41434-025-00536-7. PMID: 39315250 Free PMC article. Updated. Preprint.
Opinions on the Future of Clinical Pig Kidney Xenotransplantation.
Böhmig GA, Diebold M, Budde K. Böhmig GA, et al. Transpl Int. 2024 Nov 26;37:13475. doi: 10.3389/ti.2024.13475. eCollection 2024. Transpl Int. 2024. PMID: 39659966 Free PMC article. Review.

References

1. Organ Procurement & Transplantation Network National Data Reports. August 10,2023]; Available from: https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/
1. Aschheim K, DeFrancesco L. Xenotransplantation: how close are we? Nat Biotechnol 2023;41(4):452–460. - PubMed
1. Pierson RN 3rd, Fishman JA, Lewis GD, D’Alessandro DA, Connolly MR, Burdorf L et al. Progress Toward Cardiac Xenotransplantation. Circulation 2020;142(14):1389–1398. - PMC - PubMed
1. Reichart B, Cooper DKC, Langin M, Tonjes RR, Pierson RN, Wolf E. Cardiac xenotransplantation: from concept to clinic. Cardiovasc Res 2023;118(18):3499–3516. - PMC - PubMed
1. Tector AJ, Adams AB, Tector M. Current Status of Renal Xenotransplantation and Next Steps. Kidney360 2023;4(2):278–284. - PMC - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Elsevier Science
- PubMed Central
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Research opportunities and ethical considerations for heart and lung xenotransplantation research: A report from the National Heart, Lung, and Blood Institute workshop

Affiliations

Research opportunities and ethical considerations for heart and lung xenotransplantation research: A report from the National Heart, Lung, and Blood Institute workshop

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

Cited by

References

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous

Abstract

Conflict of interest statement

Similar articles

Cited by

References

MeSH terms

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous